Annual report pursuant to Section 13 and 15(d)

STATEMENTS OF CASH FLOWS

v3.19.1
STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Operating activities      
Net loss $ (27,897) $ (25,980) $ (12,086)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation 1,081 551 345
Loss on disposal of land, buildings, and equipment 23    
Stock-based compensation 4,385 12,092 948
Unrealized foreign exchange gain (loss) (12) (34)  
Changes in operating assets and liabilities:      
Trade accounts receivable   110 107
Due to/from related parties 676 (448) 1,702
Prepaid expenses and other assets (675) (537) (387)
Accounts payable (193) 665 53
Accrued expenses 1,558 86 137
Accrued compensation and benefits 360 613 88
Other accrued liabilities 442 97 (144)
Net cash used by operating activities (20,252) (12,785) (9,237)
Investing activities      
Purchases of land, buildings and equipment (1,847) (779) (10,424)
Other 50    
Net cash used by investing activities (1,797) (779) (10,424)
Financing activities      
Proceeds from issuance of common stock 57,706 61,292  
Costs incurred related to the issuance of common stock (665) (3,312)  
Advances from Cellectis   3,000  
Repayment of advances from Cellectis   (3,000)  
Proceeds from the exercise of stock options 2,622 265  
Purchases of common stock (230)    
Proceeds from sale and leaseback of land, buildings, and equipment 1,240 6,957  
Net cash provided by financing activities 60,673 65,202  
Net increase (decrease) in cash, cash equivalents and restricted cash 38,624 51,638 (19,661)
Cash, cash equivalents and restricted cash - beginning of period 56,664 5,026 24,687
Cash, cash equivalents and restricted cash - end of period $ 95,288 $ 56,664 $ 5,026